Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical Control

Background. Nowadays there is no consensus on the tactics and optimal protocol for Continuous Positive Airway Pressure (СРАР) at transient tachypnea of newborns (TTN) in delivery room.Objective. The aim of the study is to examine the efficacy and safety of standardized protocol of CPAP therapy for n...

Full description

Bibliographic Details
Main Authors: Evgenii V. Shestak, Olga P. Kovtun, Olga L. Ksenofontova, Dmitry S. Dodrov
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2022-10-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/3006
_version_ 1797694917592481792
author Evgenii V. Shestak
Olga P. Kovtun
Olga L. Ksenofontova
Dmitry S. Dodrov
author_facet Evgenii V. Shestak
Olga P. Kovtun
Olga L. Ksenofontova
Dmitry S. Dodrov
author_sort Evgenii V. Shestak
collection DOAJ
description Background. Nowadays there is no consensus on the tactics and optimal protocol for Continuous Positive Airway Pressure (СРАР) at transient tachypnea of newborns (TTN) in delivery room.Objective. The aim of the study is to examine the efficacy and safety of standardized protocol of CPAP therapy for newborns with TTN in delivery room.Methods. The clinical study (implementation of standardized CPAP protocol) included full-term infants (gestational age — 37–41 weeks) with diagnosed TTN and CPAP therapy during first 60 minutes of life. Similar inclusion criteria were applied for the historical control group (born within previous year for whom CPAP was implemented according to “usual” protocol). Initiation of mononasal CPAP in main group was carried out when respiratory disorders were assessed according to Downes scale ≥ 3 points with control points at 20–40–60 minutes via the same scale, in control group at ≥ 4 points — for all cases, and according to the doctor's decision at 1–3 points. Mean airway pressure was maintained at 8 and 5–10 cm H2O, CPAP duration was 20–60 and 5–30 min, respectively. The major endpoints: the frequency of patient transfer from delivery room to intensive care unit or hospitalization to the neonatal pathology department, as well as total period of hospitalization. Moreover, frequency of invasive manipulations (intravenous catheterization, parenteral feeding), antibacterial therapy, cerebral injuries (cerebral ischemia, intracerebral hemorrhage), nasal passages injuries, pneumothorax (in the first 24 hours of life) were recorded during the entire hospitalization period.Results. 140 newborns with TTN were included in the clinical study, 30 were excluded from the study, specifically 13 due to violation of the CPAP protocol. The historical control group included 165 newborns. This groups were comparable for most baseline (before the start of CPAP) indicators except for maternal COVID-19 frequency during pregnancy and twin newborns frequency. This groups were comparable for most baseline (before the start of CPAP) indicators except for the frequency of maternal COVID-19 cases during pregnancy and the frequency of twin newborns. Hospitalization rate in intensive care units (18.2 versus 70.3%; p < 0.001) and neonatal pathology departments (31.8 versus 80.0%; p < 0.001), as well as total period of hospitalization (3 versus 10 days; p < 0.001) were lower in the standardized CPAP therapy group. Lower frequency of invasive manipulations, antibacterial therapy, and cerebral ischemia was recorded in this group. The safety of СРАР administration in delivery room was confirmed by the absence of nasal passages injuries in both groups, as well as comparable frequency of pneumothorax.Conclusion. The use of standardized CPAP protocol in delivery room for full-term newborns with TTN had higher rate of favorable hospitalization outcomes. Study limitations require validation of all the findings in independent studies.
first_indexed 2024-03-12T03:04:48Z
format Article
id doaj.art-0fcc074be40a4b2ba1e8ad1d46798323
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T03:04:48Z
publishDate 2022-10-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-0fcc074be40a4b2ba1e8ad1d467983232023-09-03T14:32:59Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352022-10-0121428229210.15690/vsp.v21i4.24452046Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical ControlEvgenii V. Shestak0Olga P. Kovtun1Olga L. Ksenofontova2Dmitry S. Dodrov3Уральский государственный медицинский университет; Екатеринбургский клинический перинатальный центрУральский государственный медицинский университетЕкатеринбургский клинический перинатальный центрЕкатеринбургский клинический перинатальный центрBackground. Nowadays there is no consensus on the tactics and optimal protocol for Continuous Positive Airway Pressure (СРАР) at transient tachypnea of newborns (TTN) in delivery room.Objective. The aim of the study is to examine the efficacy and safety of standardized protocol of CPAP therapy for newborns with TTN in delivery room.Methods. The clinical study (implementation of standardized CPAP protocol) included full-term infants (gestational age — 37–41 weeks) with diagnosed TTN and CPAP therapy during first 60 minutes of life. Similar inclusion criteria were applied for the historical control group (born within previous year for whom CPAP was implemented according to “usual” protocol). Initiation of mononasal CPAP in main group was carried out when respiratory disorders were assessed according to Downes scale ≥ 3 points with control points at 20–40–60 minutes via the same scale, in control group at ≥ 4 points — for all cases, and according to the doctor's decision at 1–3 points. Mean airway pressure was maintained at 8 and 5–10 cm H2O, CPAP duration was 20–60 and 5–30 min, respectively. The major endpoints: the frequency of patient transfer from delivery room to intensive care unit or hospitalization to the neonatal pathology department, as well as total period of hospitalization. Moreover, frequency of invasive manipulations (intravenous catheterization, parenteral feeding), antibacterial therapy, cerebral injuries (cerebral ischemia, intracerebral hemorrhage), nasal passages injuries, pneumothorax (in the first 24 hours of life) were recorded during the entire hospitalization period.Results. 140 newborns with TTN were included in the clinical study, 30 were excluded from the study, specifically 13 due to violation of the CPAP protocol. The historical control group included 165 newborns. This groups were comparable for most baseline (before the start of CPAP) indicators except for maternal COVID-19 frequency during pregnancy and twin newborns frequency. This groups were comparable for most baseline (before the start of CPAP) indicators except for the frequency of maternal COVID-19 cases during pregnancy and the frequency of twin newborns. Hospitalization rate in intensive care units (18.2 versus 70.3%; p < 0.001) and neonatal pathology departments (31.8 versus 80.0%; p < 0.001), as well as total period of hospitalization (3 versus 10 days; p < 0.001) were lower in the standardized CPAP therapy group. Lower frequency of invasive manipulations, antibacterial therapy, and cerebral ischemia was recorded in this group. The safety of СРАР administration in delivery room was confirmed by the absence of nasal passages injuries in both groups, as well as comparable frequency of pneumothorax.Conclusion. The use of standardized CPAP protocol in delivery room for full-term newborns with TTN had higher rate of favorable hospitalization outcomes. Study limitations require validation of all the findings in independent studies.https://vsp.spr-journal.ru/jour/article/view/3006транзиторное тахипноэноворожденныедоношенныеродовый залсрарнеинвазивная респираторная поддержка
spellingShingle Evgenii V. Shestak
Olga P. Kovtun
Olga L. Ksenofontova
Dmitry S. Dodrov
Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical Control
Вопросы современной педиатрии
транзиторное тахипноэ
новорожденные
доношенные
родовый зал
срар
неинвазивная респираторная поддержка
title Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical Control
title_full Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical Control
title_fullStr Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical Control
title_full_unstemmed Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical Control
title_short Efficacy and Safety of Standardized Protocol of CPAP Therapy for Full-Term Newborns in Delivery Room at Transient Tachypnea: Clinical Trial with Historical Control
title_sort efficacy and safety of standardized protocol of cpap therapy for full term newborns in delivery room at transient tachypnea clinical trial with historical control
topic транзиторное тахипноэ
новорожденные
доношенные
родовый зал
срар
неинвазивная респираторная поддержка
url https://vsp.spr-journal.ru/jour/article/view/3006
work_keys_str_mv AT evgeniivshestak efficacyandsafetyofstandardizedprotocolofcpaptherapyforfulltermnewbornsindeliveryroomattransienttachypneaclinicaltrialwithhistoricalcontrol
AT olgapkovtun efficacyandsafetyofstandardizedprotocolofcpaptherapyforfulltermnewbornsindeliveryroomattransienttachypneaclinicaltrialwithhistoricalcontrol
AT olgalksenofontova efficacyandsafetyofstandardizedprotocolofcpaptherapyforfulltermnewbornsindeliveryroomattransienttachypneaclinicaltrialwithhistoricalcontrol
AT dmitrysdodrov efficacyandsafetyofstandardizedprotocolofcpaptherapyforfulltermnewbornsindeliveryroomattransienttachypneaclinicaltrialwithhistoricalcontrol